+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

DelveInsight - Market Research Reports

Delve Insight authors market leading reports across the pharmaceutical and biotechnology sectors. The key findings and insights all come from regular monitoring of developments through the pharmaceutical and biotechnology sectors. These findings are then published through market forecasts, drug pipelines and drug insights, along with advice from top market analysts on how to best use this, alongside the detailed market forecasts offered by Delve Insight.

Gaucher Disease Type 1 - Pipeline Insight, 2025 - Product Thumbnail Image

Gaucher Disease Type 1 - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Gaucher's Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Gaucher's Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Geographic Atrophy (GA)- Pipeline Insight, 2025 - Product Thumbnail Image

Geographic Atrophy (GA)- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Glaucoma - Pipeline Insight, 2025 - Product Thumbnail Image

Glaucoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 170 Pages
  • Global
From
Glioblastoma Multiforme (GBM) - Pipeline Insight, 2025 - Product Thumbnail Image

Glioblastoma Multiforme (GBM) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Glioma - Pipeline Insight, 2025 - Product Thumbnail Image

Glioma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 450 Pages
  • Global
From
HER2-Positive Early Breast Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

HER2-Positive Early Breast Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hypogonadism- Pipeline Insight, 2025 - Product Thumbnail Image

Hypogonadism- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hypoparathyroidism - Pipeline Insight, 2025 - Product Thumbnail Image

Hypoparathyroidism - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hypoxia - Pipeline Insight, 2025 - Product Thumbnail Image

Hypoxia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
IgA Nephropathy- Pipeline Insight, 2025 - Product Thumbnail Image

IgA Nephropathy- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
IgG4-Related Disease - Pipeline Insight, 2025 - Product Thumbnail Image

IgG4-Related Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Immune Thrombocytopenia (ITP) - Pipeline Insight, 2025 - Product Thumbnail Image

Immune Thrombocytopenia (ITP) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Indolent Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Indolent Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Infantile Neuroaxonal Dystrophy - Pipeline Insight, 2025 - Product Thumbnail Image

Infantile Neuroaxonal Dystrophy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Infantile Spasm - Pipeline Insight, 2025 - Product Thumbnail Image

Infantile Spasm - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Inherited Retinal Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Inherited Retinal Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Myelodysplastic Syndrome With Excess Blasts2 - Pipeline Insight, 2025 - Product Thumbnail Image

Myelodysplastic Syndrome With Excess Blasts2 - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Myocardial Infarction - Pipeline Insight, 2025 - Product Thumbnail Image

Myocardial Infarction - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
No Option Refractory Disabling Angina (NORDA) - Pipeline Insight, 2025 - Product Thumbnail Image

No Option Refractory Disabling Angina (NORDA) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator